Nuclear PTEN functions as an essential regulator of SRF-dependent transcription to control smooth muscle differentiation

Nature Communications

Volumn 7, Issue , 2016, Pages

  Horita, Henrick ^a   Wysoczynski, Christina L ^a   Walker, Lori A ^b   Moulton, Karen S ^b   Li, Marcella ^b   Ostriker, Allison ^a   Tucker, Rebecca ^a   McKinsey, Timothy A ^a,b   Churchill, Mair E A ^a   Nemenoff, Raphael A ^a   Weiser Evans, Mary C M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCARDIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE B; SERUM RESPONSE FACTOR; PTEN PROTEIN, MOUSE;

CELLS AND CELL COMPONENTS; GENE EXPRESSION; GENETIC DIFFERENTIATION; LIPID; MUSCLE; PHENOTYPE; PROTEIN; TRANSLOCATION;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PHENOTYPIC VARIATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; ANIMAL; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; PHYSIOLOGY; RAT; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY; SERUM RESPONSE FACTOR;

EID: 84960172574     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10830     Document Type: Article

References (64)

1. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809 (1993).
2. Libby, P., Ridker, P. M., Hansson, G. K. Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325 (2011).
3. Jukema, J. W., Verschuren, J. J., Ahmed, T. A., Quax, P. H. Restenosis after pci. Part 1: Pathophysiology and risk factors. Nat. Rev. Cardiol. 9, 53-62 (2012).
4. Mitra, A. K., Agrawal, D. K. In stent restenosis: Bane of the stent era. J. Clin. Pathol. 59, 232-239 (2006).
5. Alexander, M. R., Owens, G. K. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu. Rev. Physiol. 74, 13-40 (2012).
6. Owens, G. K., Kumar, M. S., Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801 (2004).
7. Owens, G. K. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found. Symp. 283, 174-191 (2007).
8. Charo, I. F., Taubman, M. B. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95, 858-866 (2004).
9. Hojo, Y. et al. Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis. Atherosclerosis 156, 165-170 (2001).
10. Schecter, A. D., Berman, A. B., Taubman, M. B. Chemokine receptors in vascular smooth muscle. Microcirculation 10, 265-272 (2003).
11. Schober, A. Chemokines in vascular dysfunction and remodeling. Arterioscler. Thromb. Vasc. Biol. 28, 1950-1959 (2008).
12. Schober, A., Zernecke, A. Chemokines in vascular remodeling. Thromb. Haemost. 97, 730-737 (2007).
13. Zeiffer, U. et al. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by p-selectin and chemokines. Circ. Res. 94, 776-784 (2004).
14. Miano, J. M. Serum response factor: toggling between disparate programs of gene expression. J. Mol. Cell. Cardiol. 35, 577-593 (2003).
15. Miano, J. M. Role of serum response factor in the pathogenesis of disease. Lab. Invest. 90, 1274-1284 (2010).
16. Sun, Q. et al. Defining the mammalian cargome. Genome Res. 16, 197-207 (2006).
17. Wang, Z. et al. Myocardin and ternary complex factors compete for srf to control smooth muscle gene expression. Nature 428, 185-189 (2004).
18. Mack, C. P. Signalling mechanisms that regulate smooth muscle cell differentiation. Arterioscler. Thromb. Vasc. Biol. 31, 1495-1505 (2011).
19. Posern, G., Treisman, R. Actin' together: Serum response factor, its cofactors and the link to signal transduction. Trends Cell. Biol. 16, 588-596 (2006).
20. Wang, D. Z., Olson, E. N. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr. Opin. Genet. Dev. 14, 558-566 (2004).
21. Yoshida, T. et al. Myocardin is a key regulator of carg-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 92, 856-864 (2003).
22. Wang, Z., Wang, D. Z., Pipes, G. C., Olson, E. N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl Acad. Sci. USA 100, 7129-7134 (2003).
23. Long, X., Bell, R. D., Gerthoffer, W. T., Zlokovic, B. V., Miano, J. M. Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 28, 1505-1510 (2008).
24. Marais, R., Wynne, J., Treisman, R. The srf accessory protein elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73, 381-393 (1993).
25. Cao, D. et al. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 25, 364-376 (2005).
26. Majesky, M. W., Dong, X. R., Regan, J. N., Hoglund, V. J. Vascular smooth muscle progenitor cells: building and repairing blood vessels. Circ. Res. 108, 365-377 (2011).
27. McDonald, O. G., Wamhoff, B. R., Hoofnagle, M. H., Owens, G. K. Control of srf binding to carg box chromatin regulates smooth muscle gene expression in vivo. J. Clin. Invest. 116, 36-48 (2006).
28. Qiu, P., Li, L. Histone acetylation and recruitment of serum responsive factor and creb-binding protein onto sm22 promoter during sm22 gene expression. Circ. Res. 90, 858-865 (2002).
29. Camoretti-Mercado, B. et al. Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J. Biol. Chem. 275, 30387-30393 (2000).
30. Kaplan-Albuquerque, N., Garat, C., Desseva, C., Jones, P. L., Nemenoff, R. A. Platelet-derived growth factor-bb-mediated activation of akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor. J. Biol. Chem. 278, 39830-39838 (2003).
31. Weiser-Evans, M. C., Quinn, B. E., Burkard, M. R., Stenmark, K. R. Transient reexpression of an embryonic autonomous growth phenotype by adult carotid artery smooth muscle cells after vascular injury. J. Cell Physiol. 182, 12-23 (2000).
32. Huang, J., Kontos, C. D. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumour suppressor protein pten. Arterioscler. Thromb. Vasc. Biol. 22, 745-751 (2002).
33. Garl, P. J. et al. Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumour suppressor pten. Circ. Res. 94, 175-183 (2004).
34. Huang, J., Niu, X. L., Pippen, A. M., Annex, B. H., Kontos, C. D. Adenovirusmediated intraarterial delivery of pten inhibits neointimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 25, 354-358 (2005).
35. Nemenoff, R. A. et al. Targeted deletion of pten in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ. Res. 102, 1036-1045 (2008).
36. Furgeson, S. B. et al. Inactivation of the tumour suppressor, pten, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc. Res. 86, 274-282 (2010).
37. Horita, H. N. et al. Serum response factor regulates expression of phosphatase and tensin homolog through a microrna network in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 31, 2909-2919 (2011).
38. Nemenoff, R. A. et al. Sdf-1alpha induction in mature smooth muscle cells by inactivation of pten is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 31, 1300-1308 (2011).
39. Dahia, P. L. Pten, a unique tumour suppressor gene. Endocr. Relat. Cancer 7, 115-129 (2000).
40. Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L., Downes, C. P. Understanding pten regulation: Pip2, polarity and protein stability. Oncogene 27, 5464-5476 (2008).
41. Tamguney, T., Stokoe, D. New insights into pten. J. Cell Sci. 120, 4071-4079 (2007).
42. Vazquez, F. et al. Phosphorylation of the pten tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J. Biol. Chem. 276, 48627-48630 (2001).
43. Vazquez, F., Ramaswamy, S., Nakamura, N., Sellers, W. R. Phosphorylation of the pten tail regulates protein stability and function. Mol. Cell. Biol. 20, 5010-5018 (2000).
44. Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., Sawyers, C. L. The pten/mmac1 tumour suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/akt pathway. Proc. Natl Acad. Sci. USA 95, 15587-15591 (1998).
45. Bassi, C. et al. Nuclear pten controls DNA repair and sensitivity to genotoxic stress. Science 341, 395-399 (2013).
46. Gu, T. et al. Creb is a novel nuclear target of pten phosphatase. Cancer Res. 71, 2821-2825 (2011).
47. Planchon, S. M., Waite, K. A., Eng, C. The nuclear affairs of pten. J. Cell Sci. 121, 249-253 (2008).
48. Song, M. S. et al. Nuclear pten regulates the apc-cdh1 tumour-suppressive complex in a phosphatase-independent manner. Cell 144, 187-199 (2011).
49. Song, M. S., Salmena, L., Pandolfi, P. P. The functions and regulation of the pten tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 (2012).
50. Li, A. G. et al. Mechanistic insights into maintenance of high p53 acetylation by pten. Mol. Cell 23, 575-587 (2006).
51. Lin, M. C. et al. Pten interacts with metal-responsive transcription factor 1 and stimulates its transcriptional activity. Biochem. J. 441, 367-377 (2012).
52. Noguera, N. I. et al. Nucleophosmin/b26 regulates pten through interaction with hausp in acute myeloid leukemia. Leukemia 27, 1037-1043 (2013).
53. Trotman, L. C. et al. Ubiquitination regulates pten nuclear import and tumour suppression. Cell 128, 141-156 (2007).
54. Pipes, G. C., Creemers, E. E., Olson, E. N. The myocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 20, 1545-1556 (2006).
55. Mack, C. P., Thompson, M. M., Lawrenz-Smith, S., Owens, G. K. Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ. Res. 86, 221-232 (2000).
56. Cagnin, S. et al. Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries. BMC Genomics 10, 13-27 (2009).
57. Tamura, M. et al. Pten interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/akt cell survival pathway. J. Biol. Chem. 274, 20693-20703 (1999).
58. Shen, W. H. et al. Essential role for nuclear pten in maintaining chromosomal integrity. Cell 128, 157-170 (2007).
59. Choi, B. H., Pagano, M., Huang, C., Dai, W. Cdh1, a substrate-recruiting component of anaphase-promoting complex/cyclosome (APC/C) ubiquitin E3 ligase, specifically interacts with phosphatase and tensin homolog (PTEN) and promotes its removal from chromatin. J. Biol. Chem. 289, 17951-17959 (2014).
60. Nelson, T. J., Balza, Jr R., Xiao, Q., Misra, R. P. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. J. Mol. Cell. Cardiol. 39, 479-489 (2005).
61. Iyer, D. et al. Serum response factor mads box serine-162 phosphorylation switches proliferation and myogenic gene programs. Proc. Natl Acad. Sci. USA 103, 4516-4521 (2006).
62. Lu, J., McKinsey, T. A., Nicol, R. L., Olson, E. N. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl Acad. Sci. USA 97, 4070-4075 (2000).
63. Martin, A. F. et al. Expression and function of COOH-terminal myosin heavy chain isoforms in mouse smooth muscle. Am. J. Physiol. Cell. Physiol. 293, C238-C245 (2007).
64. Hendrix, J. A. et al. 5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. J. Clin. Invest. 115, 418-427 (2005).